Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Hypogonadism Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…
DUBLIN–(BUSINESS WIRE)–The “Global Hypogonadism Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…
DUBLIN–(BUSINESS WIRE)–The “Global Hypogonadism Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…
DUBLIN–(BUSINESS WIRE)–The “Global Pruritus Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…
DUBLIN–(BUSINESS WIRE)–The “Global Pruritus Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…
DUBLIN–(BUSINESS WIRE)–The “Global Celiac Disease Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…
DUBLIN–(BUSINESS WIRE)–The “Global Celiac Disease Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…
DUBLIN–(BUSINESS WIRE)–The “Global Celiac Disease Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that interim…
In Phase IIIb DIALIZE trial, 41.2% of LOKELMA patients maintained normal potassium levels pre-dialysis compared to 1% receiving placebo WILMINGTON,…